Investigational Site Number : 1240001

Gatineau, Quebec J8Y 1W2

1 studies enrolling now · 5 studies all time

What they study most

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Multiple Sclerosis, Polyneuropathy, Inflammatory Demyelinating, Chronic

Studies at this site

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP — Enrolling by invitation
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Completed
• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling